The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

D••• T••••••••• I••

Drug Discovery & Developmentgroup grade Aon a schedule nowsponsor M•• B•••••••• carried
Also written as: 2; 2025; 7; 7/2/2025; Equity; Inc. and
Principal held
at least $142M
sum of BDC pieces, a lower bound
Fair value
$148M
102c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
Jul 1, 2030
no dated debt inside 24 months
On the tape since
Jun 30, 2025
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $142M102cS+245 bpJul 1, 20301
Equity pieces beside the debt: equity ($3.8M fair value, 1 BDC)
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
H••••••• C••••••• I•••equity equity
C••••• S••••
n/a$3.8M
269c
H••••••• C••••••• I•••term loan first lien
S••••• S••••••, J••• 2030, P•••• + 2.45%, F•••• rate 9.95%, 5.50% E••• Fee
$142M$144M
102c
S+245 bp
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$142M$144M102c0
Mar 31, 20261$100M$101M101c0
Dec 31, 20251$200M$202M102c0
Sep 30, 20251$65.0M$64.5M100c0
Jun 30, 20251$70.0M$69.3M100c0
What changed
Every change including routine ones
Identity
Group key
D••• T•••••••••derivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Drug Discovery & Developmentreportedas one filer wrote it